CurrentRheuma
Get Weekly

About CurrentRheuma

Making rheumatology research easier to follow.

Every week, rheumatology journals publish more new studies than anyone in practice or research can read. The results that matter are spread across many journals and are easily missed or found late.

CurrentRheuma exists to give a structured, clinically relevant overview of that research as it appears — always tied to the original publication.

How CurrentRheuma works

  1. Leading journals

    CurrentRheuma follows 23 rheumatology and general medical journals, with new research added throughout the week.

    View journals

  2. Clinical relevance

    Each new study is screened against predefined criteria for its relevance to rheumatology; what falls outside them is set aside.

    What’s included

  3. Structured Briefs

    Each eligible study is written up by AI in one fixed structure from its published abstract, checked against that abstract, and linked to the original article.

    See an example

  4. Weekly curation

    Each week the studies most worth reading are selected, three of them Featured, and published on Monday.

    This week

The founder

Who is behind CurrentRheuma?

CurrentRheuma was founded by Christian Byskov Fur, MD, a medical doctor and PhD student conducting cardiovascular research at Aarhus University, Denmark. He is also the lead investigator of the FOXY trial.

ORCID ↗, Aarhus University ↗, FOXY trial ↗ and contact@currentrheuma.com.

The platform was created to make it easier for clinicians and researchers to stay informed about newly published rheumatology research, while maintaining a clear connection to the original scientific publications.

CurrentRheuma is independent and receives no funding from pharmaceutical or device companies.